NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Clinical trial NCT06963034 · RECRUITING
Trial details
- NCT number
- NCT06963034
- Sponsor
- Neurocrine Biosciences
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-08
- Primary completion
- 2027-10-01
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.